Russian regulators get GMP training; Report probes U.S. drug distribution;

> Eli Lilly, the Chao Center for Industrial Pharmacy & Contract Manufacturing, and the Parenteral Drug Association have partnered to conduct GMP training for drug regulators in Moscow. Release

> An 80-page URCH Publishing report on U.S. pharmaceutical distribution notes that the 90 to 95 percent of sector revenue garnered by the big three--Cardinal Health, McKesson and AmerisourceBergen--has caught the eye of the Federal Trade Commission for its potential to distort the market. Release

> French biopharmaceutical maker LFB Group has chosen the Apriso FlexNet platform with RFID tracking capabilities for use in its plasma manufacturing operations. Announcement

> Specialty drug maker URL Pharma has acquired an FDA-inspected PharmPro facility in Aurora, IL, for development and manufacturing. Release 

> Generics maker West-ward Pharmaceutical, a U.S. manufacturer of generic prescription products, has opted for SaaS delivery of SmartSolve compliance and quality management products from Pilgrim Software. Announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.